Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer
Clinical trial NCT04208347 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04208347
- Sponsor
- Ruijin Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-18
- Primary completion
- 2026-12-01
- Enrollment
- 580
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.